inati-cel, CNCT19, adult, relapsed or refractory B-cell acute lymphoblastic leukaemia, CD19 CAR-T
Dual-targeting delivery, Nanoparticles, PECAM-1, TPCA-1, Uncontrolled inflammation
mathematical model, COVID-19, heterogeneity, dynamics of host immunity